LAB

Standard BioTools Inc. Common Stock

0.63

USD

+0.01

+0.79%

Oct 19, 10:50 UTC -4

Open

LAB Earnings Reports

Positive Surprise Ratio

LAB beat 17 of 37 last estimates.

46%

Next Report

Date of Next Report

Nov 10, 2026

Estimate for Q3 26 (Revenue/ EPS)

$18.99M

-$0.02

Implied change from Q2 26 (Revenue/ EPS)

-5.55%

-33.33%

Implied change from Q3 25 (Revenue/ EPS)

-2.88%

-77.78%

Standard BioTools Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, LAB reported earnings of -0.03 USD per share (EPS) for Q2 26, missing the estimate of -0.01 USD, resulting in a -129.01% surprise. Revenue reached 20.10 million, compared to an expected 21.01 million, with a -4.32% difference. The market reacted with a +2.04% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 18.99 million USD, implying an decrease of -33.33% EPS, and decrease of -5.55% in Revenue from the last quarter.

FAQ

What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Standard BioTools Inc. Common Stock reported EPS of -$0.03, missing estimates by -129.01%, and revenue of $20.10M, -4.32% below expectations.

How did the market react to Standard BioTools Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 2.04%, changed from $0.78 before the earnings release to $0.80 the day after.

When is Standard BioTools Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 10, 2026.

What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?

Based on 4 analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.02 and revenue of $18.99M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.